Cannabidiol as a Therapeutic Alternative for PTSD: From Bench to Human Trials
Post-traumatic stress disorder (PTSD) affects many and current treatments often fall short. The endocannabinoid system emotional memory is key in PTSD’s pathology. Cannabidiol shows promise as a therapeutic alternative by modulating this system.
Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series
A retrospective clinical study suggests cannabidiol in post-traumatic stress disorder treatment may reduce symptoms in adults. Eleven patients received oral CBD alongside routine care. Results showed a 28% mean reduction in PTSD severity after eight…
Use of a Synthetic Cannabinoid in a Correctional Population for PTSD-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction
Nabilone synthetic cannabinoid shows promise in treating PTSD-related insomnia and nightmares in correctional populations. It also helps manage chronic pain and supports harm reduction. This medication may reduce the need for multiple drugs in patients…
Use and effects of cannabinoids in military veterans with post-traumatic stress disorder
Cannabinoids comprise biologically active components of cannabis, such as CBD or THC, as well as their synthetic counterparts. Upon entering the body, cannabinoids activate the endogenous cannabinoid signalling system, thereby producing a wide range of…
Associations of PTSD, Chronic Pain, and Cannabis Use Disorder
PTSD chronic pain cannabis use disorder is a complex condition affecting many patients. This study highlights how PTSD and chronic pain together increase the risk of cannabis use disorder. Understanding these associations helps guide safer medical…
Use of Cannabis for Self-Management of Chronic Pelvic Pain
Chronic pelvic pain affects millions of women and can be challenging to treat. Cannabis for chronic pelvic pain is increasingly used by patients for symptom relief. Many report improvements in pain, sleep, and mood with cannabis self-management.
Cannabinoids Inhibit Human Keratinocyte Proliferation via Non-CB1/CB2 Mechanism
Cannabinoids inhibit keratinocyte proliferation, a key factor in psoriasis. This inhibition occurs through a non-CB1/CB2 receptor mechanism. These findings suggest cannabinoids have potential therapeutic value in psoriasis treatment.
Efficacy, Tolerability, and Safety of Cannabinoid Treatments in Rheumatic Diseases
The focus on cannabinoid treatments rheumatic diseases highlights their potential in managing pain and inflammation. This systematic review examines efficacy, tolerability, and safety data from randomized controlled trials. Findings suggest cautious…
Rheumatologists’ Confidence in Cannabinoids for Rheumatic Complaints
Cannabinoids and rheumatic diseases remain an area where many rheumatologists lack confidence in their knowledge. This gap affects their willingness to recommend cannabinoid treatments for rheumatic complaints. More clinical research and guidance are…
A Cannabinoid-Like Compound Modulates Neuronal Excitability, May Reduce Seizures
The cannabinoid-like compound seizure reduction potential is promising in recent research. VSN16R modulates potassium channels to reduce neuronal excitability. This mechanism may help in seizure management and epilepsy treatment.